Damora Therapeutics, Inc. — SC 13D/A Filings
8 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Damora Therapeutics, Inc. (DMRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Damora Therapeutics, Inc. has filed 8 SC 13D/A documents with the SEC since 2020. To view all SEC filings by Damora Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | SC 13D/A | 0001193125-24-167233 | Jun 24, 2024 | — |
| SC 13D/A | AMENDMENT NO. 6 | 0000947871-23-000940 | Sep 18, 2023 | — |
| SC 13D/A | AMENDMENT NO. 5 | 0000947871-23-000922 | Sep 5, 2023 | — |
| SC 13D/A | AMENDMENT NO. 4 | 0000947871-23-000872 | Aug 17, 2023 | — |
| SC 13D/A | AMENDMENT NO. 3 | 0000947871-23-000808 | Aug 2, 2023 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000947871-23-000752 | Jul 17, 2023 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000947871-23-000437 | Apr 7, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-255659 | Sep 30, 2022 | — |